Chemical Component Summary

Name4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid
Identifiers4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloranyl-indol-2-yl]butanoic acid
FormulaC19 H15 Cl N2 O4 S2
Molecular Weight434.916
TypeNON-POLYMER
Isomeric SMILESc1cc2c(cc1S(=O)(=O)n3c4ccc(cc4cc3CCCC(=O)O)Cl)scn2
InChIInChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15-5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
InChIKeyOQDQIFQRNZIEEJ-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count43
Chiral Atom Count0
Bond Count46
Aromatic Bond Count20

Drug Info: DrugBank

DrugBank IDDB14801 
NameLanifibranor
Groups investigational
DescriptionLanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).
SynonymsLanifibranor
Categories
  • Amides
  • Heterocyclic Compounds, Fused-Ring
  • Sulfones
  • Sulfur Compounds
  • Thiazoles
CAS number927961-18-0

Related Resource References

Resource NameReference
PubChem 68677842
ChEMBL CHEMBL4091374